All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Paediatric familial hypercholesterolaemia screening in Europe - public policy background and recommendations.

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00209775%3A_____%2F22%3AN0000011" target="_blank" >RIV/00209775:_____/22:N0000011 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216224:14110/22:00127655

  • Result on the web

    <a href="https://academic.oup.com/eurjpc/article/29/18/2301/6691825?login=false" target="_blank" >https://academic.oup.com/eurjpc/article/29/18/2301/6691825?login=false</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1093/eurjpc/zwac200" target="_blank" >10.1093/eurjpc/zwac200</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Paediatric familial hypercholesterolaemia screening in Europe - public policy background and recommendations.

  • Original language description

    Familial hypercholesterolaemia (FH) is under-recognized and under-treated in Europe leading to significantly higher risk for premature heart disease in those affected. As treatment beginning early in life is highly effective in preventing heart disease and cost-effective in these patients, screening for FH is crucial. It has therefore now been recognized by the European Commission Public Health Best Practice Portal as an effective strategy. Model programmes exist in Europe to identify young individuals with FH, which are based on cascade screening of first-degree relatives of affected individuals, universal screening for high cholesterol, opportunistic screening of high-risk individuals, or a combination of the above approaches. Recommendations presented herein to improve identification of FH emphasize that every country should have an FH screening programme. These programmes should be adapted from existing strategies to best fit the individual country's healthcare system, governments should provide financial support for these programmes and related care, and further research to optimize care and implementations should be conducted.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30202 - Endocrinology and metabolism (including diabetes, hormones)

Result continuities

  • Project

    <a href="/en/project/LX22NPO5104" target="_blank" >LX22NPO5104: National Institute for Research of Metabolic and Cardiovascular Diseases</a><br>

  • Continuities

    P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Others

  • Publication year

    2022

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    European Journal of Preventive Cardiology

  • ISSN

    2047-4873

  • e-ISSN

    2047-4881

  • Volume of the periodical

    29

  • Issue of the periodical within the volume

    18

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    11

  • Pages from-to

    2301–2311

  • UT code for WoS article

    000860847200001

  • EID of the result in the Scopus database

    2-s2.0-85140631500